Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
54
RNA Quote, Financials, Valuation and Earnings
Last price:
$72.19
Seasonality move
:
29.53%
Day range:
$72.05 - $72.19
52-week range:
$21.51 - $72.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
453.94x
P/B ratio:
5.76x
Volume:
1.2M
Avg. volume:
2.8M
1-year change:
128%
Market cap:
$10.9B
Revenue:
$10.9M
EPS (TTM):
-$4.17
Earnings Data
Next earnings date for RNA
Mar 02
2026
Most recent earnings per share
-$1.27
Missed by $0.16
(Nov 10/2025)
Consensus Estimate
-$1.10
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RNA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/02/2026 | Q4 | $2M | -- | -- | -$1.25 | -- |
| 11/10/2025 | Q3 | $1.8M | $12.5M | -$1.27 | -$1.10 | -$0.16 |
| 08/08/2025 | Q2 | $1.6M | $3.8M | -$1.21 | -$0.96 | -$0.26 |
| 05/08/2025 | Q1 | $2.6M | $1.6M | -$0.90 | -$0.88 | -$0.02 |
| 02/27/2025 | Q4 | $1.7M | $3M | -$0.80 | -$0.78 | -$0.01 |
| 11/07/2024 | Q3 | $4.6M | $2.3M | -$0.65 | -$0.72 | $0.07 |
| 08/09/2024 | Q2 | $3M | $2M | -$0.66 | -$0.78 | $0.12 |
| 05/09/2024 | Q1 | $2.6M | $3.5M | -$0.79 | -$0.88 | $0.09 |
| 02/28/2024 | Q4 | $12.2M | $2.2M | -$0.79 | -$0.63 | -$0.16 |
| 11/08/2023 | Q3 | -- | $2.8M | -$0.71 | -- | -- |
| 08/08/2023 | Q2 | -- | $2.3M | -$0.66 | -- | -- |
| 05/09/2023 | Q1 | -- | $2.2M | -$0.74 | -- | -- |
| 02/28/2023 | Q4 | -- | $2.8M | -$0.88 | -- | -- |
| 11/08/2022 | Q3 | -- | $2.5M | -$0.82 | -- | -- |
| 08/09/2022 | Q2 | -- | $2.2M | -$0.92 | -- | -- |
| 05/10/2022 | Q1 | -- | $1.8M | -$0.71 | -- | -- |
| 03/01/2022 | Q4 | -- | $1.9M | -$0.82 | -- | -- |
| 11/09/2021 | Q3 | -- | $2.2M | -$0.68 | -- | -- |
| 08/09/2021 | Q2 | -- | $2.6M | -$0.70 | -- | -- |
| 05/12/2021 | Q1 | -- | $2.7M | -$0.64 | -- | -- |
| 03/15/2021 | Q4 | -- | $2.1M | -$0.43 | -- | -- |
| 11/10/2020 | Q3 | -- | $1.7M | -$0.31 | -- | -- |
| 08/10/2020 | Q2 | -- | $1.5M | -$0.28 | -- | -- |
| 03/31/2020 | Q1 | -- | $1.4M | -$0.16 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.50 | -- | -- |
| 09/30/2019 | Q3 | -- | $650K | -$2.43 | -- | -- |
| 06/30/2019 | Q2 | -- | $224K | -$0.14 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.07 | -- | -- |
Avidity Biosciences, Inc. Earnings Questions
-
How Much did Avidity Biosciences, Inc. Generate in Revenue Last Quarter?
Avidity Biosciences, Inc. reported $12.5M worth of top line sales in its most recent quarter.
-
Did Avidity Biosciences, Inc. Beat Earnings Last Quarter?
Avidity Biosciences, Inc. announced earnings per share of -$1.27 which represents a miss of analyst forecast a -$1.10 per share.
-
Is Avidity Biosciences, Inc. Profitable?
Avidity Biosciences, Inc. reported $11.4M that represents $0.08 per share over the last quarter.
-
What is the Analyst Consensus for Avidity Biosciences, Inc. EPS Next Year?
Avidity Biosciences, Inc.'s earnings are forecast to decrease from -$2.89 per share to -$2.86 per share next year representing a decrease of -55.41%.
-
When is Avidity Biosciences, Inc.'s Earnings Date?
Avidity Biosciences, Inc.'s next earnings date is March 2, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
